Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michihiro Mutoh is active.

Publication


Featured researches published by Michihiro Mutoh.


Journal of Ethnopharmacology | 1999

Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells.

Kazunori Fukuda; Yuko Hibiya; Michihiro Mutoh; Masatoshi Koshiji; Seigou Akao; Hisayoshi Fujiwara

The enzyme cyclooxygenase-2 (COX-2) is abundantly expressed in colon cancer cells and plays a key role in colon tumorigenesis. Compounds inhibiting COX-2 transcriptional activity have therefore potentially a chemopreventive property against colon tumor formation. An assay method for estimating COX-2 transcriptional activity in human colon cancer cells was established using a beta-galactosidase reporter gene system, and examination was made of various medicinal herbs and their ingredients for an inhibitory effect on COX-2 transcriptional activity. We found that berberine, an isoquinoline alkaloid present in plants of the genera Berberis and Coptis, effectively inhibits COX-2 transcriptional activity in colon cancer cells in a dose- and time-dependent manner at concentrations higher than 0.3 microM. The present findings may further explain the mechanism of anti-inflammatory and anti-tumor promoting effects of berberine.


Japanese Journal of Cancer Research | 2000

Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship.

Michihiro Mutoh; Mami Takahashi; Kazunori Fukuda; Hajime Komatsu; Takeji Enya; Yuko Matsushima-Hibiya; Hiroshi Mutoh; Takashi Sugimura; Keiji Wakabayashi

Cyclooxygenase‐2 (COX‐2) plays an important role in carcinogenesis. Investigation of the suppressive action of twelve flavonoids of different chemical classes on the transcriptional activity of the COX‐2 gene in human colon cancer DLD‐1 cells using a reporter gene assay have revealed quercetin to be the most potent suppressor of COX‐2 transcription (IC50=10.5 μM), while catechin and epicatechin showed weak activity (IC50=415.3 μM). Flavonoids have three heterocyclic rings as a common structure. A structure‐activity study indicated that the number of hydroxyl groups on the B ring and an oxo group at the 4‐position of the C ring are important in the suppression of COX‐2 transcriptional activity. A low electron density of the oxygen atom in the hydroxyl group of the A ring was also important. Further examination of the role of the hydroxyl group in the A ring showed that bromination of resacetophenone to give 3,5‐dibromo‐2,4‐dihydroxyacetophenone resulted in a 6.8‐fold increase in potency for suppressing COX‐2 promoter activity. These results provide a basis for the design of improved suppressors of COX‐2 transcriptional activity.


Biochemical Pharmacology | 2000

Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1

Kazunori Fukuda; Yuko Hibiya; Michihiro Mutoh; Yasushi Ohno; Kazuya Yamashita; Seigou Akao; Hisayoshi Fujiwara

Excessive nitric oxide production by inducible nitric oxide synthase (iNOS) in stimulated inflammatory cells is thought to be a causative factor of cellular injury in inflammatory disease states. Compounds inhibiting iNOS transcriptional activity in inflammatory cells are potentially anti-inflammatory. An assay method for estimating iNOS transcriptional activity in the human monocyte cell line THP-1 was established using a luciferase reporter gene system. In this study, we demonstrate that parthenolide, the predominant sesquiterpene lactone in European feverfew (Tanacetum parthenium), exerts potent inhibitory effects on the promoter activity of the iNOS gene in THP-1 cells. Parthenolide effectively suppressed iNOS promoter activity in a dose-dependent manner at concentrations higher than 2. 5 microM, with an IC(50) of about 10 microM. A tumor-promoting phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA), significantly increased the iNOS promoter-dependent reporter gene activity, and the TPA-induced increase in iNOS promoter activity was effectively suppressed by parthenolide, with an IC(50) of approximately 2 microM. The present findings may further explain the anti-inflammatory property of parthenolide.


Cancer Letters | 2002

Suppression of promoter-dependent transcriptional activity of inducible nitric oxide synthase by sodium butyrate in colon cancer cells

Yasuyoshi Sasahara; Michihiro Mutoh; Mami Takahashi; Kazunori Fukuda; Naomi Tanaka; Takashi Sugimura; Keiji Wakabayashi

Butyrate suppresses the growth of colon cancer cells, inducing differentiation and apoptosis in vitro. Increased expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) has been suggested to be closely involved in colon carcinogenesis. In this study, effects of sodium butyrate on the promoter-dependent transcriptional activity of iNOS and COX-2 genes were investigated in a colon cancer cell line, DLD-1, using a reporter gene assay system. Sodium butyrate significantly reduced promoter-dependent iNOS transcriptional activity dose-dependently at concentrations higher than 0.1 mM. COX-2 transcriptional activity was not suppressed, but slightly increased. While hyperacetylated histones appeared at concentrations of sodium butyrate suppressing iNOS gene promoter activity, promoter-dependent transcriptional activities of iNOS and COX-2 genes were both increased by the histone deacetylase inhibitor trichostatin A. These results suggested that sodium butyrate exhibits differential effects on iNOS and COX-2 genes, acting to suppress iNOS expression via mechanisms independent of histone acetylation.


Archive | 2016

Potential for Sesame Seed-Derived Factors to Prevent Colorectal Cancer

Shingo Miyamoto; Gen Fujii; Masami Komiya; Masaru Terasaki; Michihiro Mutoh

Colorectal cancers (CRCs) are steadily increasing in most advanced countries, including Japan. The mechanisms of colon carcinogenesis have yet to be fully elucidated, but it is assumed that factors, such as insulin resistance, dyslipidemia, inflammation, and subsequent adipocytokine imbalance, might be involved in the promotion of colorectal carcinogenesis. In this chapter, we focus on the chemopreventive effects of natural compounds, especially sesame seed-derived factors on colorectal carcinogenesis, with the current status and future prospects for CRC chemoprevention. Furthermore, molecules suggested to be involved in CRC development are described, and the potential for cancer prevention by targeting NADPH oxidase is also discussed with respect to its inhibitors.


Carcinogenesis | 2000

Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure

Michihiro Mutoh; Mami Takahashi; Kazunori Fukuda; Yuko Matsushima-Hibiya; Hiroshi Mutoh; Takashi Sugimura; Keiji Wakabayashi


Planta Medica | 1999

Inhibition of activator protein 1 activity by berberine in human hepatoma cells.

Kazunori Fukuda; Yuko Hibiya; Michihiro Mutoh; Masatoshi Koshiji; Seigou Akao; Hisayoshi Fujiwara


Clinical Cancer Research | 2002

Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: crucial role of arachidonate metabolism in tumor growth and progression.

Toru Asano; Junichi Shoda; Tetsuya Ueda; Toru Kawamoto; Takeshi Todoroki; Manabu Shimonishi; Tadashi Tanabe; Yukihiko Sugimoto; Atsushi Ichikawa; Michihiro Mutoh; Naomi Tanaka; Masanao Miwa


Archive | 2009

Method of inhibiting intestinal polyps

Keiji Wakabayashi; Michihiro Mutoh


The Japanese Biochemical Society/The Molecular Biology Society of Japan | 2017

Effects of a highly-bioavailable curcumin on mouse intestinal carcinogenesis.

Takahiro Hamoya; Saeko Adati; Shingo Miyamoto; Gen Fujii; Ruri Nakanishi; Masami Komiya; Shuya Tamura; Yurie Kurokawa; Maiko Takahashi; Jiro Toshima; Kosuke Tashiro; Michihiro Mutoh

Collaboration


Dive into the Michihiro Mutoh's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masafumi Yamamoto

Central Institute for Experimental Animals

View shared research outputs
Researchain Logo
Decentralizing Knowledge